PROS1 and COVID-19: This raises questions about effectiveness of antibodies in protection from re-infection and for management strategies like COVID-19 recovered status as measure of “immunity passport.” Most efforts regarding vaccine development against COVID-19 are focused on generating neutralizing antibodies against viral spike protein.